The Journal of Immunology opened 2018 with a special topical review on cancer immunotherapy, assembling more than 10 reviews on topics critical to translating tumor immunology to clinical success; topics include immunosurveillance, mutated antigens as T cell targets, vaccine strategies, metabolism, CAR T cells, cellular and molecular forms of immunosuppression, and strategies to effectively overcome that suppression.
With this editorial, I am pleased to introduce he
Cancer Immunotherapy Revolution: Mechanistic
Insights,the second topical issue of reviews
published in The Journal of Immunology. In acknowledgment
of the growing interest in immuno-oncology and building on
the success of our first topical issue of Brief Reviews, he
Macro Influence of the Microbiome,we now publish a series
of 10 Brief Reviews and 1 Translating Immunology article
highlighting the principles, applications, and challenges immunologists
and cancer specialists face in this new era of
tumor immunology and its clinical partner, cancer immunotherapy